Exposure-response modeling of the ACR20 score in rheumatoid arthritis patients treated with certolizumab pegol

被引：0
|
作者：
Lacroix, B. [1 ,2 ]
Lovern, M. [1 ]
Stockis, A. [1 ]
Sargentini-Maier, M. L. [1 ]
Karisson, M. O. [2 ]
Friberg, L. E. [2 ]
机构：
[1] UCB Pharma SA, Pharmacometr, Braine Lalleud, Belgium
[2] Uppsala Univ, Div Pharmacokinet & Drug Therapy, Uppsala, Sweden
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
42
引用
下载
收藏
页码：1107 / 1107
页数：1
相关论文
共 50 条
  • [21] Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease
    Vande Casteele, N.
    Feagan, B. G.
    Vermeire, S.
    Yassine, M.
    Coarse, J.
    Kosutic, G.
    Sandborn, W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 229 - 237
  • [22] Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 1: Binary Model)
    Li, Liang
    Zhang, Yi
    Ma, Lian
    Ji, Ping
    Yim, Sarah
    Chowdhury, Badrul
    Doddapaneni, Suresh
    Liu, Jiang
    Wang, Yaning
    Sahajwalla, Chandrahas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1097 - 1106
  • [23] Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: Continuous Model)
    Li, Liang
    Zhang, Yi
    Ma, Lian
    Ji, Ping
    Yim, Sarah
    Chowdhury, Badrul A.
    Doddapaneni, Suresh
    Liu, Jiang
    Wang, Yaning
    Sahajwalla, Chandrahas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1107 - 1125
  • [24] EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS
    Carlino, G.
    Cozzolongo, A.
    Maggio, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1049 - 1049
  • [25] Exposure-Response Relationship for Certolizumab Pegol During the Induction Phase in Patients With Crohn's Disease
    Vande Casteele, Niels
    Stitt, Larry
    Spearman, Marshall
    Kosutic, Gordana
    Oliver, Ruth
    Coarse, Jason
    Feagan, Brian G.
    Sandborn, William
    GASTROENTEROLOGY, 2016, 150 (04) : S409 - S409
  • [26] Synovial Ectopic Lymphoneogenesis Predicts Clinical Response To Certolizumab Pegol In Patients With Rheumatoid Arthritis
    Di Cicco, Maria
    Kelly, Stephen
    Humby, Frances
    Ng, Nora
    Dadoun, Sabrina
    Hands, Rebecca
    Rocher, Vidalba
    Nerviani, Alessandra
    Bombardieri, Michele
    Pitzalis, Costantino
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S556 - S556
  • [27] ACR20 RESPONSE AS SURROGATE OF ACR70 RESPONSE IN RHEUMATOID ARTHRITIS: A TRIALLEVEL ANALYSIS FROM A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
    Koon, A. Ah
    Confavreux, C.
    Grenet, G.
    Mainbourg, S.
    Larbre, J. P.
    Coury, F.
    Lega, J. C.
    Massy, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 314 - 315
  • [28] Functional MRI shows a faster Response of Certolizumab-Pegol in Patients with Rheumatoid Arthritis
    Rech, J.
    Finzel, S.
    Kreitz, S.
    Englbrecht, M.
    Sergeeva, M.
    Roesch, J.
    Doerfler, A.
    Hess, A.
    Schett, G.
    INTERNIST, 2013, 54 : 55 - 55
  • [29] Exposure-Response Modeling and Simulation of the Efficacy Endpoints in Rheumatoid Arthritis
    Ma, Lian
    Ji, Ping
    Wang, Yaning
    Zhao, Liang
    Xu, Yun
    Doddapaneni, Suresh
    Sahajwalla, Chandrahas G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S73 - S73
  • [30] Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept
    Goldman, J. A.
    Xia, H. A.
    White, B.
    Paulus, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1649 - 1652
12345